Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma

Blood Adv. 2022 Apr 26;6(8):2466-2470. doi: 10.1182/bloodadvances.2021006178.

Authors

Meera Mohan¹, Sneha Nagavally¹, Binod Dhakal¹, Sabarinath Venniyil Radhakrishnan¹, Saurabh Chhabra¹, Anita D'Souza¹, Parameswaran Hari¹

Affiliation

¹ Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI.

No abstract available

MeSH terms

B-Cell Maturation Antigen
Humans
Immunologic Factors
Immunotherapy
Multiple Myeloma* / therapy
Receptors, Chimeric Antigen*

Substances

B-Cell Maturation Antigen
Immunologic Factors
Receptors, Chimeric Antigen